Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation.

ABSTRACT:

SUBMITTER: Dimou A 

PROVIDER: S-EPMC7450917 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature